Clinical Trial Update: Envafolimab Combined With Recombinant Human Endostatin and First-line Chemotherapy Treat of Advanced Mucosal Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating envafolimab combined with recombinant human endostatin and first-line chemotherapy for advanced mucosal melanoma is ongoing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucosal Melanoma

Drugs mentioned

• Envafolimab (envafolimab)
• Recombinant human endostatin (recombinant human endostatin)

Snippet

Sponsor: Fudan University | Conditions: Advanced Mucosal Melanoma | Phase 2 | Status: UNKNOWN